Literature DB >> 6882253

Eye findings in patients with phenylketonuria.

J Zwaan.   

Abstract

Untreated phenylketonuria (PKU) is characterized by excretion of phenylpyruvic acid in the urine and mental retardation. Reported eye abnormalities include photophobia (probably due to the albinoid iris), cataracts, and corneal opacities. Eleven patients in an institutionalized population of approximately 1,000 mentally retarded patients had PKU. Cataracts were found in six patients. One patient had bilateral phthisis bulbi and one patient had monocular phthisis. No corneal opacities were found otherwise. All patients with cataracts were middle-aged or had a history of severe self-induced trauma or treatment with high dosages of thioridazine hydrochloride. Albinism is associated with anomalous chiasmal routing of optic fibers and abnormal, extraocular motility. The ocular hypopigmentation of patients with PKU did not have the same results; all seeing patients were orthophoric. Although eye abnormalities are common in PKU except for hypopigmentation, none can be considered a direct effect of the inborn error of metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6882253     DOI: 10.1001/archopht.1983.01040020238016

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Altered visual functions, macular ganglion cell and papillary retinal nerve fiber layer thickness in early-treated adult PKU patients.

Authors:  Csilla Serfozo; Andras Gellert Barta; Endre Horvath; Csaba Sumanszki; Bela Csakany; Miklos Resch; Zoltan Zsolt Nagy; Peter Reismann
Journal:  Mol Genet Metab Rep       Date:  2020-09-22

Review 2.  Phenylketonuria does not cause cataracts.

Authors:  D B Pitt; J O'Day
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

3.  Reduced macular thickness and macular vessel density in early-treated adult patients with PKU.

Authors:  Csilla Serfozo; Andras Gellert Barta; Endre Horvath; Csaba Sumanszki; Bela Csakany; Miklos Resch; Zoltan Zsolt Nagy; Peter Reismann
Journal:  Mol Genet Metab Rep       Date:  2021-05-05

4.  Saccadic reaction time and ocular findings in phenylketonuria.

Authors:  Susanne Hopf; Caroline Nowak; Julia B Hennermann; Irene Schmidtmann; Norbert Pfeiffer; Susanne Pitz
Journal:  Orphanet J Rare Dis       Date:  2020-05-25       Impact factor: 4.123

5.  CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria.

Authors:  Kuldeep Singh; Cathleen S Cornell; Robert Jackson; Mostafa Kabiri; Michael Phipps; Mitul Desai; Robert Fogle; Xiaoyou Ying; Gulbenk Anarat-Cappillino; Sarah Geller; Jennifer Johnson; Errin Roberts; Katie Malley; Tim Devlin; Matthew DeRiso; Patricia Berthelette; Yao V Zhang; Susan Ryan; Srinivas Rao; Beth L Thurberg; Dinesh S Bangari; Sirkka Kyostio-Moore
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.